Menopausal issues

Sexuality and Disability

Volumn 17, Issue 3, 1999, Pages 259-267

  Welner, Sandra L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DEPRESSION; DISABILITY; ESTROGEN METABOLISM; HUMAN; MENOPAUSE; REVIEW;

EID: 0033396329     PISSN: 01461044     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022185123624     Document Type: Review

References (51)

1. Ruzek, SB: Demographic Changes that Impact on Women's Health. In: The Textbook of Women's Health, Lippincott-Raven, Philadelphia, PA, 1998, pg. 28.
2. Staas, WE Jr., Formal, CS, Freedman, MK, et al: Spinal Cord Injury and Spinal Cord Injury Medicine. In: Rehabilitation Medicine: Principles and Practice Third Ed. Lippincott-Raven, Philadelphia, PA, 1998, pg, 1273-1274.
3. Coney P, and Cefalo, RC. Menopause: Acceptance and Understanding of its Impact. In: Women's Primary Health Care - Office Practice and Procedures, McGraw-Hill, 1995, pg. 19.
4. Grinstead L, Heltberg A, Hagen, C, et al: Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. Inter Med 226: 241-244, 1989.
5. Hoek A, Van Kasteren Y, Se Haan-Meulman M, et al: Dysfunction of monocytes and dendritic cells in patients with premature ovarian failure. Am J Reprod Immunol 30:207-217, 1993.
6. Welner, S (in press): Obstetric and Gynecological Issues Confronting Women with Disabilities. In: Gynecology and Obstetrics (Sciarra, ed), J.B. Lippincott Company.
7. Varila E, Rantala I, Oikarinen A, et al: The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 102(12):985-9, 1995.
8. Lichtman R: Perimenopausal and postmenopausal hormone replacement therapy. Part 1. An update of the literature on benefits and risks. J Nurse Midwifery 41(1):3-28, 1996.
9. Sipski, M: Spinal Cord Injury and Sexual Function: An Education Model. In: Sexual Function in People with Disability and Chronic Illness (M Sipski, C Alexander, eds), Aspen Publishing, Gaithersburg, Maryland, 1997, pg. 154.
10. Smeltzer, SC and Kelley, CL: Multiple Sclerosis. In: Sexual Function in People with Disability and Chronic Illness (M Sipski, C Alexander, eds), Aspen Publishing, Gaithersburg, Maryland, 1997, pg. 185.
11. Coope J: Hormonal and non-hormonal interventions for menopausal symptoms. Maturitas 23(2):159-68, 1996.
12. Backstrom T: Symptoms related to the menopause and sex steroid treatments. Ciba Found Symp 1995.
13. Welner, S: Contraception, STDs and Menopause. In: Women with Physical Disabilities: Achieving and Maintaining Health and Well-Being (Krotoski DM, Nosek MA, Turk MA, eds), Paul H Brookes Company, Baltimore, MD, pg. 87.
14. Welner, S: Reproductive Endocrinology and Disability. In: Infertility and Reproductive Medicine Clinics of North America (C Davis, ed), W.B. Saunders Company, Philadelphia, 1998, pg. 692.
15. Ostensen M, Rugelsjoen, A and Wigers, SH: The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 26(5): 355-60, 1997.
16. Herzog, AG: Reproductive Endocrine Considerations and Hormonal Therapy for Women with Epilepsy. Epilepsia 32(Suppl. 6): S27-S33, 1991.
17. Homer, J: Depression in the Primary Care Setting. In: The Medical Care of Women (PL Carr, KM Freund, S Somani, eds), W.B. Saunders Company, Philadelphia, 1995, pg. 729.
18. Panay, N and Studd, JW: The psychotherapeutic effects of estrogens. Gynecol Endcrinol 12(5): 353-365, 1998.
19. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140: 256-261, 1994.
20. Sandyk, R: Estrogen's impact on cognitive functions in multiple sclerosis. Int J Neurosci 86(1-2):23-31, 1996.
21. Moroney JT, Bagiella E, Tatemichi, TK, et al: Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 48(5): 1317-25, 1997.
22. Emilien, G and Waltregny, A: Traumatic brain injury, cognitive and emotional dysfunction. Acta Neuro Belg 96(2): 89-101, 1996.
23. Polo-Kantola, P, Erkkola, R, Helemus, H, et al: When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 178(5):1002-1009, 1998.
24. Vital Statistics of the United States Mortality Part A, The National Center for Health Statistics, Hyattsville, MD, 1986.
25. Healthy People 2000 Review 1997, National Center for Health Statistics, Hyattsville, MD Public Health Service 1997, pg. 6-7.
26. Grodstein, F, Stampfer, JJ, Goldhaber, SZ, et al: Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 348: 983-987, 1996.
27. Speroff, L, Rowan, J, Symons, J, et al: The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study). JAMA, 276:1397-1403, 1996.
28. Karas, RH, Patterson, BL, Mendelsohn, ME: Human vascular smooth muscle cells contain functional estrogen receptors. Circulation 89: 1943-1950, 1994.
29. Collins, P, Rosario, GM, Jiand, C, et al: Cardiovascular protection by estrogen: a calcium antagonistic effect? Lancet 341: 1264-1265, 1993.
30. Castelo-Branco C, Casals E, Sanllehy, C, et al: Postmenopausal hormone replacement therapy with low-dose medroxyprogesterone acetate. J Reprod Med 40, 305-311, 1995.
31. Mikkola T, Viinikka L, and Ylikorkala, O: Estrogen and postmenopausal estrogen/progesting therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production. Eur J Obstet Gynecol Reprod Biol 79(1): 75-82, 1998.
32. Paganini-Hill A: Estrogen replacement therapy in the elderly. Zentralbl Gynakol 118(5):255-61, 1996.
33. Jiang, C, Sarrel, PM, Lindsay, DC, et al: Endothelium-independent relaxation of rabbit coronary artery by 17-oestradiol in vitro. Br J Pharmacol 104: 1033-1037, 1991.
34. Roux C: Estrogen therapy in postmenopausal osteoporosis. What we know and what we don't. Rev Rhum Engl Ed 64(6): 402-409, 1997.
35. Cardozo, LD and Kelleher CJ: Sex hormones, the menopause and urinary problems. Gynecol Endocrinol 9(1): 75-84, 1995.
36. Barentsen R, van de Wijer PH and Scrham JH: Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 71(1): 73-80, 1997.
37. Rosenson, S, Tangney CC, Mosca LJ: Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women. Arterioscler Thromb Vasc Biol 18(12): 1902-1905, 1998.
38. Greendale, GA and Judd HL: Menopause, In: The Medical Care of Women, (PL Carr, KM Freund, S Somani, eds), W.B. Saunders Company, Philadelphia, 1995, pg. 631.
39. Wallis LA, Barbo DM: Hormone replacement therapy. In: The Textbook of Women's Health, Lippincott-Raven, Philadelphia, PA, 1998, pg. 734-735.
40. Bolaji II, Mortimer G, Grimes H, et al: Clinical evaluation of near-continuous oral micronized progesterone therapy in estrogenized postmenopausal women. Gynecol Endocrinol 10(1): 41-7, 1996.
41. Powles TJ, Bourne T, Athanasiou S, et al: The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. W Br J Cancer 78(2):272-5, 1998.
42. Shahar E, Folsom AR, Salomaa VV, et al: Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 93(11):1970-5, 1996.
43. Koh KK, Mincemoyer R, Bui MN, et al: Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. NEJM 336(10):683-90, 1997.
44. ARTERIOSCLER THROMB VASC BIOL 1996 Jun; 16(6).
45. PROC ASSOC AM PHYSICIANS 1996 Jan; 108(1).
46. Colditz GA, Stampfer MJ, Willett, WC, et al: Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 264: 2648-2653, 1990.
47. Bryant HU and Dere WH: Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc Soc Exp Biol Med 217(1): 45-52, 1998.
48. Balfour JA and Goa K: Raloxifene. Drugs Aging 12(4): 335-41, 1998.
49. Gustafsson JA: Therapeutic potential of selective estrogen receptor modulators. Curr Opin Chem Biol 2(4) 508-511, 1998.
50. Zava DT, Dollbaum CM and Bien M: Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 217(3):369-78, 1998.
51. Lieberman, S: A Review of the Effectiveness of Cimicifuga racemosa (Black Cohosh) for the Symptoms of Menopause. Women's Health 7(5): 525-529.